Cargando…

S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS

Detalles Bibliográficos
Autores principales: Gleitz, Hélène, Snoeren, Inge, Fuchs, Stijn, Nagai, James, Dugourd, Aurélien, Boys, Charlotte, Klöker, Vanessa, Pritchard, Jessica, Bindels, Eric, Te Boekhorst, Peter André Willem, Crysandt, Martina, Saez-Rodriguez, Julio, Vogl, Thomas, Kramann, Rafael, Costa, Ivan, Schneider, Rebekka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428437/
http://dx.doi.org/10.1097/01.HS9.0000967732.36177.f7
_version_ 1785090469042061312
author Gleitz, Hélène
Snoeren, Inge
Fuchs, Stijn
Nagai, James
Dugourd, Aurélien
Boys, Charlotte
Klöker, Vanessa
Pritchard, Jessica
Bindels, Eric
Te Boekhorst, Peter André Willem
Crysandt, Martina
Saez-Rodriguez, Julio
Vogl, Thomas
Kramann, Rafael
Costa, Ivan
Schneider, Rebekka
author_facet Gleitz, Hélène
Snoeren, Inge
Fuchs, Stijn
Nagai, James
Dugourd, Aurélien
Boys, Charlotte
Klöker, Vanessa
Pritchard, Jessica
Bindels, Eric
Te Boekhorst, Peter André Willem
Crysandt, Martina
Saez-Rodriguez, Julio
Vogl, Thomas
Kramann, Rafael
Costa, Ivan
Schneider, Rebekka
author_sort Gleitz, Hélène
collection PubMed
description
format Online
Article
Text
id pubmed-10428437
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284372023-08-17 S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS Gleitz, Hélène Snoeren, Inge Fuchs, Stijn Nagai, James Dugourd, Aurélien Boys, Charlotte Klöker, Vanessa Pritchard, Jessica Bindels, Eric Te Boekhorst, Peter André Willem Crysandt, Martina Saez-Rodriguez, Julio Vogl, Thomas Kramann, Rafael Costa, Ivan Schneider, Rebekka Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428437/ http://dx.doi.org/10.1097/01.HS9.0000967732.36177.f7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Gleitz, Hélène
Snoeren, Inge
Fuchs, Stijn
Nagai, James
Dugourd, Aurélien
Boys, Charlotte
Klöker, Vanessa
Pritchard, Jessica
Bindels, Eric
Te Boekhorst, Peter André Willem
Crysandt, Martina
Saez-Rodriguez, Julio
Vogl, Thomas
Kramann, Rafael
Costa, Ivan
Schneider, Rebekka
S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
title S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
title_full S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
title_fullStr S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
title_full_unstemmed S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
title_short S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
title_sort s205: inhibiting the alarmin-driven hematopoiesis-stromal cells crosstalk in primary myelofibrosis ameliorates bone marrow fibrosis
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428437/
http://dx.doi.org/10.1097/01.HS9.0000967732.36177.f7
work_keys_str_mv AT gleitzhelene s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT snoereninge s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT fuchsstijn s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT nagaijames s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT dugourdaurelien s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT boyscharlotte s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT klokervanessa s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT pritchardjessica s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT bindelseric s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT teboekhorstpeterandrewillem s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT crysandtmartina s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT saezrodriguezjulio s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT voglthomas s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT kramannrafael s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT costaivan s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis
AT schneiderrebekka s205inhibitingthealarmindrivenhematopoiesisstromalcellscrosstalkinprimarymyelofibrosisamelioratesbonemarrowfibrosis